The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 26, Issue 2, 2002, Pages 202-208

  Venkayya, Rajeev ^a   Lam, Maggie ^a   Willkom, Madeleine ^a   Grünig, Gabriele ^a   Corry, David B ^a   Erle, David J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; RAG 1 PROTEIN; RAG-1 PROTEIN; STAT6 PROTEIN; STAT6 PROTEIN, HUMAN; STAT6 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

ANIMAL; ARTICLE; ASTHMA; BAGG ALBINO MOUSE; BRONCHUS HYPERREACTIVITY; C57BL MOUSE; CD4+ T LYMPHOCYTE; CELL CULTURE; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; EPITHELIUM CELL; GENETICS; HUMAN; IMMUNOLOGY; LUNG; LUNG LAVAGE; LYMPHOCYTE ACTIVATION; MAST CELL; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; RESPIRATORY TRACT MUCOSA; SIGNAL TRANSDUCTION; TH2 CELL;

ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; EPITHELIAL CELLS; HOMEODOMAIN PROTEINS; HUMANS; INTERLEUKIN-13; INTERLEUKIN-4; LUNG; LYMPHOCYTE ACTIVATION; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, INTERLEUKIN-4; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR; TH2 CELLS; TRANS-ACTIVATORS;

EID: 0036007308     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.26.2.4600     Document Type: Article

References (41)

1. Forecasted state-specific estimates of self-reported asthma prevalence - United States, 1998
2. The pathobiology of bronchial asthma
3. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma
4. Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma
5. + T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia
6. Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice
7. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins
8. Functional diversity of helper T lymphocytes
9. Interleukin-13: Central mediator of allergic asthma
10. Requirement for IL-13 independently of IL-4 in experimental asthma
11. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithellal fibrosis, physiologic abnormalities, and eotaxin production
12. Epithelium-dependent contraction of airway smooth muscle caused by eosinophil MBP
13. Eosinophil supernatant causes hyperresponsiveness of airway smooth muscle in guinea pig trachea
14. Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle: Role of the epithelium
15. Differences between IL-4R alpha-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses
16. Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling
17. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells
18. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity
19. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization
20. Mast cell activation enhances airway responsiveness to methacholine in the mouse
21. An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model
22. Prostaglandin D2 as a mediator of allergic asthma
23. Anti-cytokine antibodies as carrier proteins: Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes
24. Soluble cytokine receptors as carrier proteins: Effects of soluble interleukin-4 receptors on the pharmacokinetics of murine interleukin-4
25. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15
26. Essential role of Stat6 in IL-4 signalling
27. Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production
28. Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice
29. Interleukin 4 receptors on human bronchial epithelial cells: An in vivo and in vitro analysis of expression and function
30. Biochemical and morphological characterization of vascular and lymphocytic interleukin-4 receptors
31. Cytokines induce airway smooth muscle cell hyperresponsiveness to contractile agonists
32. Regulation of TH1- and TH2-type cytokine expression and action in atopic asthmatic sensitized airway smooth muscle
33. Inhibition of inducible nitric oxide synthase expression by interleukin- 4 and interleukin-13 in human lung epithelial cells
34. Effect of interleukin-4 on the synthesis of the third component of complement by pulmonary epithelial cells
35. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma
36. Cutting edge: Guinea pigs with a natural C3a-receptor defect exhibit decreased bronchoconstriction in allergic airway disease: Evidence for an involvement of the C3a anaphylatoxin in the pathogenesis of asthma
37. A role for the C3a anaphylatoxin receptor in the effector phase of asthma
38. IL-4 directly modulates function of a model human intestinal epithelium
39. Interleukin-4 receptor in moderate atopic asthma: A phase I/II randomized, placebo-controlled trial
40. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
41. The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyperresponsiveness is overcome by interleukin-5